90 related articles for article (PubMed ID: 1702253)
1. Binding of enteric bacteria to hog gastric mucin.
Kétyi I
Acta Microbiol Hung; 1990; 37(1):45-53. PubMed ID: 1702253
[TBL] [Abstract][Full Text] [Related]
2. Feeding by mucin and intestinal growth of some enteric bacterial pathogens.
Kétyi I
Acta Microbiol Hung; 1988; 35(4):389-95. PubMed ID: 2469280
[TBL] [Abstract][Full Text] [Related]
3. Exoproducts of the Escherichia coli strain H22 inhibiting some enteric pathogens both in vitro and in vivo.
Cursino L; Smajs D; Smarda J; Nardi RM; Nicoli JR; Chartone-Souza E; Nascimento AM
J Appl Microbiol; 2006 Apr; 100(4):821-9. PubMed ID: 16553738
[TBL] [Abstract][Full Text] [Related]
4. Studies on specificity of protection induced by immunization with outer membrane proteins of Shigella.
Witkowska D; Mulczyk M; Adamus G
Arch Immunol Ther Exp (Warsz); 1985; 33(5):625-8. PubMed ID: 3914866
[TBL] [Abstract][Full Text] [Related]
5. Changes in outer membrane protein profiles of bacteria after meropenem-induced postantibiotic effect studied by capillary electrophoresis.
Kustos I; Kocsis B; Kerepesi I; Kilár F
Electrophoresis; 1998 Oct; 19(13):2324-30. PubMed ID: 9788316
[TBL] [Abstract][Full Text] [Related]
6. Biofilm model experiments in vitro with Escherichia coli and Shigella strains.
Kétyi I
Acta Microbiol Hung; 1989; 36(1):41-50. PubMed ID: 2690554
[TBL] [Abstract][Full Text] [Related]
7. The role of lipopolysaccharides in the action of the bactericidal/permeability-increasing neutrophil protein on the bacterial envelope.
Weiss J; Muello K; Victor M; Elsbach P
J Immunol; 1984 Jun; 132(6):3109-15. PubMed ID: 6373924
[TBL] [Abstract][Full Text] [Related]
8. [Elimination of the R-factor and inhibition of episomic drug resistance in enteric bacteria by antihistaminics].
Shenderov BA
Biull Eksp Biol Med; 1972 Jun; 73(6):55-8. PubMed ID: 4403220
[No Abstract] [Full Text] [Related]
9. Studies on nonspecific protection induced with OMP of Shigella flexneri and other genera of Enterobacteriaceae.
Czarny A; Witkowska D; Mulczyk M
Arch Immunol Ther Exp (Warsz); 1990; 38(5-6):353-7. PubMed ID: 2130800
[TBL] [Abstract][Full Text] [Related]
10. Immunogenic and protective properties of outer membrane proteins of Hafnia alvei.
Witkowska D; Czarny A; Mulczyk M
Arch Immunol Ther Exp (Warsz); 1990; 38(5-6):387-93. PubMed ID: 2130804
[TBL] [Abstract][Full Text] [Related]
11. Potential Shigella flexneri 2a and Shigella sonnei I live vaccinal strains. Characterization of immunogenicity in animal models.
Denchev V; Sumerska T; Marinova S; Vassilev T; Panova I; Linde K
Acta Microbiol Hung; 1990; 37(4):359-66. PubMed ID: 2099082
[TBL] [Abstract][Full Text] [Related]
12. [The inductive immunosuppressive activity of the nonspecific lipopolysaccharide fraction of virulent Shigella sonnei].
Borisova EV; Borisov VA
Mikrobiol Z; 1997; 59(1):77-81. PubMed ID: 9172868
[TBL] [Abstract][Full Text] [Related]
13. Mucin degradation in human colon ecosystems. Degradation of hog gastric mucin by fecal extracts and fecal cultures.
Variyam EP; Hoskins LC
Gastroenterology; 1981 Oct; 81(4):751-8. PubMed ID: 7262519
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol binding by the bacterial type III translocon is essential for virulence effector delivery into mammalian cells.
Hayward RD; Cain RJ; McGhie EJ; Phillips N; Garner MJ; Koronakis V
Mol Microbiol; 2005 May; 56(3):590-603. PubMed ID: 15819617
[TBL] [Abstract][Full Text] [Related]
15. Some biological properties of outer membrane proteins of Shigella.
Witkowska D; Czarny A; Mulczyk M
Arch Immunol Ther Exp (Warsz); 1987; 35(6):759-62. PubMed ID: 3334007
[TBL] [Abstract][Full Text] [Related]
16. Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine.
Oaks EV; Turbyfill KR
Vaccine; 2006 Mar; 24(13):2290-301. PubMed ID: 16364513
[TBL] [Abstract][Full Text] [Related]
17. [Chick embryos as a model for studying colicine biosynthesis in bacteria of the enteric family].
Emel'ianova OI
Lab Delo; 1974; (12):740-2. PubMed ID: 4140966
[No Abstract] [Full Text] [Related]
18. Improved methods for producing outer membrane vesicles in Gram-negative bacteria.
Henry T; Pommier S; Journet L; Bernadac A; Gorvel JP; Lloubès R
Res Microbiol; 2004; 155(6):437-46. PubMed ID: 15249060
[TBL] [Abstract][Full Text] [Related]
19. Mucin degradation in human colon ecosystems. Isolation and properties of fecal strains that degrade ABH blood group antigens and oligosaccharides from mucin glycoproteins.
Hoskins LC; Agustines M; McKee WB; Boulding ET; Kriaris M; Niedermeyer G
J Clin Invest; 1985 Mar; 75(3):944-53. PubMed ID: 3920248
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of transcriptional regulatory elements of glutamate-dependent acid-resistance systems of Shigella flexneri and Escherichia coli O157:H7.
Bhagwat AA; Bhagwat M
FEMS Microbiol Lett; 2004 May; 234(1):139-47. PubMed ID: 15109732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
